Released December 21, 2018 | SUGAR LAND
en
The biotech manufacturing industry is realizing three overarching trends: evaluation of single-use systems; continuous manufacturing; and increased collection and analysis of data and the use of artificial intelligence.
Benefits of single-use systems include: 1) cost reduction-no sterilization, maintenance of bioreactors, cleaning; 2) increased productivity; 3) easy disposal; 4) less water usage; 5) time savings; and 6) reduced risk of cross-contamination.
Benefits of continuous manufacturing include: 1) processing times are decreased, unnecessary steps are eliminated, and the entire process is streamlined from start to finish (no more stops and starts); 2) less physical footprint; 3) lower cost of goods; and 4) less risk for contamination.
Finally, as the world becomes highly automated, the biotech industry is increasing usage of high-tech automation and artificial intelligence to complement and control the manufacturing process. This trend will only become more pronounced in the coming years. Think of it as Biotech Manufacturing 4.0.
Benefits of single-use systems include: 1) cost reduction-no sterilization, maintenance of bioreactors, cleaning; 2) increased productivity; 3) easy disposal; 4) less water usage; 5) time savings; and 6) reduced risk of cross-contamination.
Benefits of continuous manufacturing include: 1) processing times are decreased, unnecessary steps are eliminated, and the entire process is streamlined from start to finish (no more stops and starts); 2) less physical footprint; 3) lower cost of goods; and 4) less risk for contamination.
Finally, as the world becomes highly automated, the biotech industry is increasing usage of high-tech automation and artificial intelligence to complement and control the manufacturing process. This trend will only become more pronounced in the coming years. Think of it as Biotech Manufacturing 4.0.
